ICU Medical, Incorporated  

(Public, NASDAQ:ICUI)   Watch this stock  
Find more results for Jack McCall�
98.10
-0.86 (-0.87%)
Jul 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 97.19 - 98.86
52 week 56.62 - 99.74
Open 98.83
Vol / Avg. 95,412.00/130,045.00
Mkt cap 1.56B
P/E 52.87
Div/yield     -
EPS 1.86
Shares 15.78M
Beta 0.59
Inst. own 90%
Aug 10, 2015
Q2 2015 ICU Medical Inc Earnings Call - 4:30PM EDT - Add to calendar
Aug 10, 2015
Q2 2015 ICU Medical Inc Earnings Release - 4:00PM EDT - Add to calendar
Jun 15, 2015
ICU Medical Inc Annual Shareholders Meeting - Webcast
May 5, 2015
Q1 2015 ICU Medical Inc Earnings Call - Webcast
May 5, 2015
Q1 2015 ICU Medical Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 11.89% 8.52%
Operating margin 13.47% 12.62%
EBITD margin - 20.56%
Return on average assets 7.09% 5.06%
Return on average equity 7.57% 5.41%
Employees 2,280 -
CDP Score - -

Address

951 Calle Amanecer
SAN CLEMENTE, CA 92673
United States - Map
+1-949-3662183 (Phone)
+1-949-3668368 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ICU Medical, Inc. is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and innovative hemodynamic monitoring systems. The Company’s products are used in acute care hospitals and ambulatory clinics in more than 60 countries worldwide. Its products are categorized into three market segments: Infusion Therapy, Critical Care and Oncology. Its primary products include MicroClave and MicroClave Clear, Anti-Microbial MicroClave, Tego needlefree hemodialysis connector, Transpac disposable pressure transducers, Pulmonary artery thermodilution catheters, ChemoLock CSTD and components, and Diana hazardous drug compounding system, among others.

Officers and directors

Vivek Jain Chairman of the Board, Chief Executive Officer
Age: 42
Bio & Compensation  - Reuters
Scott E. Lamb Chief Financial Officer
Age: 52
Bio & Compensation  - Reuters
Steven C. Riggs Vice President - Operations
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alison D. Burcar Vice President, General Manager - Infusion Systems
Age: 42
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tom McCall Vice President, General Manager - Critical Care
Age: 57
Bio & Compensation  - Reuters
John J. Connors Esq. Lead Independent Director
Age: 74
Bio & Compensation  - Reuters
George A. Lopez M.D. Director
Age: 67
Bio & Compensation  - Reuters
Jack W. Brown Independent Director
Age: 76
Bio & Compensation  - Reuters
Joseph R. Saucedo Independent Director
Age: 72
Bio & Compensation  - Reuters
Richard H. Sherman M.D. Independent Director
Age: 68
Bio & Compensation  - Reuters